Medical Marijuana News Channel

Medical Marijuana News Channel

Friday, January 2, 2015

Cannabis and Cannabinoids - an Overview

















Cannabis , also known as marijuana, is a plant grown in many parts of the world which produces a resin containing compounds called cannabinoids. Some cannabinoids are psychoactive (acting on the brain and changing mood or consciousness).

The use of Cannabis for medicinal purposes dates back to ancient times.

By federal law, the use, sale, and possession of Cannabis is illegal in the United States. However, a growing number of states and the District of Columbia have enacted laws to legalize medical marijuana.

In the United States, Cannabis is a controlled substance requiring special licensing for its use.

Cannabinoids are active chemicals in Cannabis that cause drug -like effects throughout the body, including the central nervous system and the immune system.

Cannabinoids can be taken by mouth, inhaled, or sprayed under the tongue.

Cannabis and cannabinoids have been studied in the laboratory and the clinic for relief of pain, nausea and vomiting, anxiety, and loss of appetite.

Cannabis and cannabinoids may have benefits in treating the symptoms of cancer or the side effects of cancer therapies.

Two cannabinoids (dronabinol and nabilone) are drugs approved by the U.S. Food and Drug Administration (FDA) for the prevention or treatment of chemotherapy -related nausea and vomiting.

Cannabis has been shown to kill cancer cells in the laboratory and to affect the immune system. However, there is no evidence that Cannabis' effects on the immune system help the body fight cancer.

At this time, there is not enough evidence to recommend that patients inhale or ingest Cannabis as a treatment for cancer-related symptoms or side effects of cancer therapy.

Cannabis is not approved by the FDA for use as a cancer treatment.


Story Source: The above story is based on materials provided by NATIONALCANCERINSTITUTE
Note: Materials may be edited for content and length
Click here to read original article

No comments:

Post a Comment